CS257769B2 - Method of oral pharmaceutical preparations production - Google Patents

Method of oral pharmaceutical preparations production Download PDF

Info

Publication number
CS257769B2
CS257769B2 CS834636A CS463683A CS257769B2 CS 257769 B2 CS257769 B2 CS 257769B2 CS 834636 A CS834636 A CS 834636A CS 463683 A CS463683 A CS 463683A CS 257769 B2 CS257769 B2 CS 257769B2
Authority
CS
Czechoslovakia
Prior art keywords
release
mixture
microcapsules
water
drug
Prior art date
Application number
CS834636A
Other languages
Czech (cs)
English (en)
Other versions
CS463683A2 (en
Inventor
Anders G V Kaellstrand
Kjell J Mattson
Rolf I Sjoeqvist
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of CS463683A2 publication Critical patent/CS463683A2/cs
Publication of CS257769B2 publication Critical patent/CS257769B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
CS834636A 1982-06-24 1983-06-23 Method of oral pharmaceutical preparations production CS257769B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8203953A SE8203953D0 (sv) 1982-06-24 1982-06-24 Pharmaceutical mixture

Publications (2)

Publication Number Publication Date
CS463683A2 CS463683A2 (en) 1987-11-12
CS257769B2 true CS257769B2 (en) 1988-06-15

Family

ID=20347191

Family Applications (1)

Application Number Title Priority Date Filing Date
CS834636A CS257769B2 (en) 1982-06-24 1983-06-23 Method of oral pharmaceutical preparations production

Country Status (29)

Country Link
EP (1) EP0101418B1 (de)
JP (1) JPS5916822A (de)
KR (1) KR910000028B1 (de)
AR (1) AR231075A1 (de)
AT (1) ATE59286T1 (de)
AU (1) AU561954B2 (de)
BG (1) BG51341A3 (de)
CA (1) CA1214726A (de)
CS (1) CS257769B2 (de)
CY (1) CY1468A (de)
DD (1) DD209971A5 (de)
DE (1) DE3382086D1 (de)
DK (1) DK161365C (de)
ES (1) ES8403720A1 (de)
FI (1) FI85213C (de)
GB (1) GB2122490B (de)
GR (1) GR78604B (de)
HK (1) HK98786A (de)
HU (1) HU189300B (de)
IE (1) IE55204B1 (de)
IS (1) IS1325B6 (de)
MY (1) MY8700292A (de)
NO (1) NO168745C (de)
NZ (1) NZ204639A (de)
PH (1) PH21911A (de)
PT (1) PT76919B (de)
SE (1) SE8203953D0 (de)
SU (1) SU1722207A3 (de)
ZA (1) ZA833931B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0729927B2 (ja) * 1983-04-09 1995-04-05 日研化学株式会社 テオフィリン徐放性製剤
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
IT1183575B (it) * 1985-05-08 1987-10-22 Eurand Spa Formulazione deodorando ad effetto modulante sulla trfaspirazione
NL8503539A (nl) * 1986-01-02 1987-07-16 Warner Lambert Co Sucrose-vrije preparaten.
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US5427935A (en) * 1987-07-24 1995-06-27 The Regents Of The University Of Michigan Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes
SE463542B (sv) * 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer instanticerbar produkt samt foerfarande foer dess framstaellning
US5064650A (en) * 1988-04-19 1991-11-12 Southwest Research Institute Controlled-release salt sensitive capsule for oral use and adhesive system
JPH03504968A (ja) * 1988-04-19 1991-10-31 サウスウェスト・リサーチ・インスティチュート 塩感受性シェル物質を有するカプセルからの活性成分の制御放出
FR2653337B1 (fr) * 1989-10-23 1992-02-07 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5364634A (en) * 1991-11-08 1994-11-15 Southwest Research Institute Controlled-release PH sensitive capsule and adhesive system and method
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
DE4312656C2 (de) * 1993-04-19 1996-01-25 Beiersdorf Ag Kühlend wirkende kosmetische oder dermatologische Zusammensetzungen
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
DK0826376T3 (da) * 1995-05-02 2007-04-16 Taisho Pharmaceutical Co Ltd Sammensætning til oral indgivelse
DE19706978A1 (de) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Kombinationspräparat für oral applizierbare Antibiotika
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636568A (de) * 1961-01-31
US3689654A (en) * 1970-09-14 1972-09-05 Morton Norwich Products Inc Pharmaceutical compositions
GB1506016A (en) * 1974-02-22 1978-04-05 Wellcome Found Pharmaceutical preparations
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
JPS57209223A (en) * 1981-06-19 1982-12-22 Tanabe Seiyaku Co Ltd Microcapsule for intracranial anti hypotension and its production

Also Published As

Publication number Publication date
NO832293L (no) 1983-12-27
IS1325B6 (is) 1988-08-03
ZA833931B (en) 1984-07-25
DK272383A (da) 1983-12-25
PH21911A (en) 1988-04-08
IE831462L (en) 1983-12-24
MY8700292A (en) 1987-12-31
GB2122490B (en) 1986-04-03
PT76919B (en) 1986-04-09
GB2122490A (en) 1984-01-18
FI832197A0 (fi) 1983-06-16
NO168745B (no) 1991-12-23
AU561954B2 (en) 1987-05-21
KR910000028B1 (ko) 1991-01-19
HU189300B (en) 1986-06-30
DK161365B (da) 1991-07-01
CY1468A (en) 1989-07-21
SE8203953D0 (sv) 1982-06-24
KR840005024A (ko) 1984-11-03
FI85213B (fi) 1991-12-13
PT76919A (en) 1983-07-01
ATE59286T1 (de) 1991-01-15
JPS5916822A (ja) 1984-01-28
NZ204639A (en) 1986-01-24
ES523536A0 (es) 1984-04-01
BG51341A3 (en) 1993-04-15
FI85213C (fi) 1992-03-25
CS463683A2 (en) 1987-11-12
GB8317071D0 (en) 1983-07-27
EP0101418A3 (en) 1984-11-14
DK272383D0 (da) 1983-06-14
AU1594383A (en) 1984-01-05
FI832197L (fi) 1983-12-25
CA1214726A (en) 1986-12-02
DD209971A5 (de) 1984-05-30
DE3382086D1 (de) 1991-02-07
SU1722207A3 (ru) 1992-03-23
AR231075A1 (es) 1984-09-28
IE55204B1 (en) 1990-07-04
GR78604B (de) 1984-09-27
JPH0559089B2 (de) 1993-08-30
NO168745C (no) 1992-04-01
DK161365C (da) 1991-12-09
EP0101418A2 (de) 1984-02-22
IS2824A7 (is) 1983-12-25
EP0101418B1 (de) 1990-12-27
HK98786A (en) 1986-12-24
ES8403720A1 (es) 1984-04-01

Similar Documents

Publication Publication Date Title
US4994260A (en) Pharmaceutical mixture
CS257769B2 (en) Method of oral pharmaceutical preparations production
CA1317883C (en) Liquid dosage form for oral administration of a pharmaceutically active substance
JP4077886B2 (ja) 不溶性薬剤の持効性ヘテロ分散ヒドロゲル系
JP2653996B2 (ja) 徐放性薬剤
US5368861A (en) Gastric preparation with sustained release
US5811126A (en) Controlled release matrix for pharmaceuticals
JP3667778B2 (ja) スフェロイド製剤
US4702918A (en) Pharmaceutical preparations and a method of manufacturing them
US5238686A (en) Sustained-release pharmaceutical preparation
ES2237163T3 (es) Nuevas formulaciones orales de revastigmina de liberacion controlada.
US4199560A (en) Solid oral pharmaceutical product with increased efficacy and predetermined steady state of solubility
JP2626248B2 (ja) カプセル剤
EP0076515B1 (de) Mikropellets mit schneller Wirkstofffreisetzung und Verfahren zu ihrer Herstellung
PT85213B (pt) Processo para a preparacao de composicoes farmaceuticas de libertacao prolongada para administracao oral contendo um polimero celusosico
JPH0460968B2 (de)
EP0248447A2 (de) Formulierungen mit verzögerter Freisetzung
PT85819B (pt) Processo para a preparacao de membranas de revestimento e de composicoes farmaceuticas obtidas a partir delas
PT1492511E (pt) Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
HU204998B (en) Process for producing peroral pharmaceuticdal compositions comprising buspirone and its salts
KR0171413B1 (ko) 젬피브로질 제제
JPWO2004108164A1 (ja) コーティング用組成物およびコーティング製剤